Veritable, L.P. Charles River Laboratories International, Inc. Transaction History

Veritable, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$255.51 - $362.11 $149,728 - $212,196	-586 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $14,757 - $18,844	-42 Reduced 6.69%	586 $221,000
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $11,179 - $13,749	-30 Reduced 4.56%	628 $259,000
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $28,240 - $35,678	-96 Reduced 12.73%	658 $243,000
Q1 2021 May 17, 2021	BUY	$249.67 - $299.48 $188,251 - $225,807	754 New	754 $219,000
Q3 2018 Nov 14, 2018	SELL	$112.11 - $134.54 $295,970 - $355,185	-2,640 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$102.37 - $117.25 $32,963 - $37,754	322 Added 13.89%	2,640 $296,000
Q1 2018 May 14, 2018	BUY	$98.19 - $115.2 $227,604 - $267,033	2,318 New	2,318 $247,000

691

51.6M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.38B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

Stay updated on Veritable, L.P. with notifications on news.